News

These findings highlight a host-intrinsic mechanism responsible for the failure of PD-L1 blockade in ovarian cancer.

Immunotherapy, targeted radiation, and a refined surgical technique allowed tumour removal in a liver cancer patient previously ineligible for surgery.

Tirzepatide reduces LV mass and paracardiac fat in obesity-related HFpEF, offering structural heart benefits beyond weight loss.

A wearable device reduced fatigue and Raynaud symptoms in systemic sclerosis, improving quality of life without adverse effects.

A new retrospective study has identified key risk factors for methotrexate (MTX) treatment failure in tubal ectopic pregnancy (TEP). The findings suggest that higher gravidity and elevated β-hCG levels increase the likelihood of treatment failure, while additional MTX doses improve success rates.

Researchers uncover genetic variants that drive cancer risk, revealing new therapeutic targets and refining genetic screening strategies.

The ECDC’s Annual Epidemiological Reports analysed surveillance data from 29 EU/EEA countries, tracking trends in gonorrhoea, syphilis, and chlamydia.

A new study suggests that infants who consume a high-fibre diet before their first birthday may have a significantly lower risk of developing celiac disease.